Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy

BACKGROUND: Maspin, a non-inhibitory member of the serine protease inhibitor superfamily, has been characterized as a tumor suppressor gene in multiple cancer types. Chemotherapeutic insensitivity is one of major obstacles to effectively treating muscle invasive bladder cancer (MIBC). This study was...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Exp Clin Cancer Res
Asıl Yazarlar: Chen, Jinbo, Wang, Long, Tang, Yunhua, Gong, Guanghui, Liu, Longfei, Chen, Minfeng, Chen, Zhi, Cui, Yu, Li, Chao, Cheng, Xu, Qi, Lin, Zu, Xiongbing
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4702361/
https://ncbi.nlm.nih.gov/pubmed/26733306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-015-0282-y
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller